JAZZ
Jazz Pharmaceuticals plc
NASDAQ · IEHealthcareBiotechnology
$243.47-1.64%
Price as of Jul 20, 2026
JAZZ profitability
Jazz Pharmaceuticals plc profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 84.1%
- EBITDA margin
- 12.3%
- EBIT margin
- 11.1%
- Net margin
- 0.7%
- Free cash flow margin
- 28.1%
Returns
- Return on equity
- 0.7%
- Return on assets
- 0.2%
- Return on invested capital
- 5.0%
- Asset turnover
- 0.38x
Cash efficiency
- Cash from operations
- $1.3B
- Cash per share
- $46
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.